Participants are also randomly assigned randomized to receive intermittent malaria prophylaxis by either two doses or more than two doses of combined sulfadoxine-pyrimethamine (a single dose represented 1500 mg sulfadoxine and 75mg pyrimethamine). The malaria component will be analysed separately.